Clinical trial
Optimal MTX Dose With Folic Acid Randomized Case-control Trial
NCT04066803
Study timeline
Study start (actual)2018-08-01Date precision: day
Registry last updated2019-08-26
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Rheumatoid Arthritisunresolved
Interventions
Sponsors & collaborators
Sun Yat-sen Universitylead sponsor
Shanghai Pharmaceuticals Holding Co., Ltdcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04066803 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.